Search results for: Consulting Reports
Filter search results
Obstructive Sleep Apnoea: Health Economics Report
1 September 2014
…85% of OSA cases currently are undiagnosed and untreated in the UK. In this report, OHE Consulting calculates the direct savings that could be realised if more cases were treated….
Four Case Studies to Explore the Added Value of Oxford AHSN
9 January 2016
…in 2013. In order to do this, OHE Consulting and RAND Europe conducted analyses of four case study projects: 1. Anxiety & Depression Clinical Network: A targeted 5% improvement in…
Data Governance Arrangements for Real-World Evidence: South Korea
1 September 2017
…“ideal”, facilitative framework for data governance. 1 Cole, A., Garrison, L., Mestre-Ferrandiz, J., & Towse, A. (2015). Data Governance Arrangements for Real-World Evidence. OHE Consulting Report, London: Office of Health…
The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries
5 January 2018
…to vary according to indication and – critically – according to value. This OHE Consulting report, funded by AstraZeneca, provides an overview of the key literature that has contributed to…
Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation
1 December 2018
…are poorly understood, particularly in relation to the new General Data Protection Regulation (GDPR). In this consulting report, sponsored by the European Federation of Pharmaceutical Industries and Associations (EFPIA), we…
Exploring the Financial Sustainability of Gene Therapies
5 January 2021
…Journal of Health Economics, DOI: https://doi.org/10.1007/s10198-018-1007-x Hampson G, Mott D, Shah K, Devlin N., 2018. Public Preferences for Health Gains and Cures: A Discrete Choice Experiment. OHE Consulting Report, London:…
After the Transplant: Potential Benefits for the NHS and UK Kidney Transplant Patients
1 November 2021
…available, particularly through improved post-transplant care that can increase the likelihood of a successful transplant and extend the duration of graft survival, ideally to one transplant for life. This Consulting…
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
1 January 2022
…to ensure that future tumour-agnostic therapies are assessed consistently. Funding: This consulting report was commissioned and funded by F. Hoffmann-La Roche Ltd. Medical writing support for the development of this…
Jon Sussex
28 November 2023
…Centre for Health Economics. Before joining the OHE in 1997, Jon was a management consultant at Deloitte & Touche Consulting where he specialised in health care and regulatory economics. Prior…